Skip to content

A 1647 · New York · 2025-2026 · Billy

Skip to content

Home
/
Bills
/
New York
/
2025-2026
/
A 1647

New York · 2025-2026 session · house

A 1647Relates to decriminalizing the possession of buprenorphine

Status: In committee
Latest action: 2026-01-08 — AMEND BY RESTORING TO ORIGINAL PRINT 1647
Primary sponsor: Linda Rosenthal (Democratic)

Track this bill View changes+188 / −121 words · Large

Sponsors

Linda Rosenthal (Democratic) · primaryprimary
Jeffrey Dinowitz (Democratic) · cosponsor

Public legislative record via Billy. Sign in to track, annotate, and export work product.

About public bill pages Compare Billy New York bill RSS

Jo Anne Simon (Democratic) · cosponsor

Karines Reyes (Democratic) · cosponsor

Phil Steck (Democratic) · cosponsor

JGJessica Gonzalez-Rojas · cosponsor

Chris Burdick (Democratic/Independence/Working Families) · cosponsor

ZMZohran Mamdani · cosponsor

Phara Souffrant Forrest (Democratic) · cosponsor

Andrew Hevesi (Democratic) · cosponsor

Catalina Cruz (Democratic) · cosponsor

Sarah Clark (Democratic/Working Families) · cosponsor

Versions

A1647—
A1647A—

Legislative history

Jan 8, 2026
AMEND BY RESTORING TO ORIGINAL PRINT 1647
Jan 7, 2026
REFERRED TO CODES
Jun 6, 2025
AMEND AND RECOMMIT TO CODES
Jun 6, 2025
PRINT NUMBER 1647A
Jan 10, 2025
REFERRED TO CODES

Official sources

Version 0PDF HTML
Version 1PDF

About this page

Is this the official New York bill page?: No — this is Billy’s public legislative record for A 1647. Official source links are listed above when publishers provide them.
Can I track updates?: Yes. Sign in to track A 1647, get alerts, annotate diffs, and export Word work product.